Naurex announces GLYX-13 molecule recognized in Top 10 to Watch” list for depression treatment
September 2nd, 2010
More info…Naurex Inc., a clinical stage company developing innovative treatments for depression and other CNS disorders, today reported that its clinical stage candidate for the treatment of depression, GLYX-13, and its second-generation NRX-1050 series have been selected for inclusion on Windhover’s list of the “Top 10 Most Interesting Neuroscience Projects to Watch.” types of depression [...]
Posted in Depression Types, Teenage Depression | Comments (0)
Forest-Gedeon Richter drug misses overall goal
September 1st, 2010
More info…TEL AVIV (MarketWatch) — Forest Laboratories Inc. and Gedeon Richter PLC said Monday that in a Phase II study of cariprazine, a potential treatment for bipolar depression, the overall result for patients taking the drug was not statistically different from that of the patients taking placebo. In higher doses, however, the antipsychotic drug did [...]
Posted in Childhood Depression, Clinical Depression, Depression Types, Teenage Depression | Comments (0)
New Thoughts On Brain Research
August 29th, 2010
More info…The first annual national conference on translational brain research will be held at The Australian National University on Monday. What: Translational Research in the Brain: Accelerating the Pathway from Discovery to Healthcare… depression types Share and Enjoy:
Posted in Childhood Depression, Depression Types, Severe Depression | Comments (0)
Tags
Categories
Recent Posts
- Free course helps families cope with mental illness
- Naurex announces GLYX-13 molecule recognized in Top 10 to Watch” list for depression treatment
- Forest-Gedeon Richter drug misses overall goal
- Bipolar Advantage Announces New Program ‘Providing Solutions to the Bipolar Economy’
- Why believers in immortality must read Super Sad True Love Story